|
HS Code |
202456 |
| Iupac Name | 6-chloroimidazo[1,2-a]pyridine-3-carbaldehyde |
| Cas Number | 760212-61-9 |
| Molecular Formula | C8H5ClN2O |
| Molecular Weight | 180.59 |
| Appearance | Yellow to orange solid |
| Melting Point | 126-130°C |
| Solubility | Soluble in DMSO and DMF |
| Purity | Typically >98% |
| Smiles | C1=CN2C=CN=CC2=C1ClC=O |
| Inchi | InChI=1S/C8H5ClN2O/c9-7-1-2-11-6(4-12)3-10-8(7)5-11/h1-5H |
| Storage Conditions | Store at 2-8°C, keep container tightly closed |
As an accredited 6-Chloroimidazo[1,2-a]pyridine-3-carbaldehyde factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging is a 5-gram amber glass vial, securely sealed, with a printed label stating "6-Chloroimidazo[1,2-a]pyridine-3-carbaldehyde." |
| Container Loading (20′ FCL) | Container Loading (20′ FCL) for 6-Chloroimidazo[1,2-a]pyridine-3-carbaldehyde ensures secure, bulk transport in sealed, moisture-free packaging. |
| Shipping | 6-Chloroimidazo[1,2-a]pyridine-3-carbaldehyde is shipped in secure, sealed containers compliant with chemical safety regulations. Packaging ensures protection from moisture, light, and physical damage. The shipment includes appropriate labeling, hazard information, and documentation, and is handled by licensed carriers following local and international transport guidelines for potentially hazardous chemicals. |
| Storage | **6-Chloroimidazo[1,2-a]pyridine-3-carbaldehyde** should be stored in a tightly closed, light-resistant container at room temperature (15–25°C), in a cool, dry, well-ventilated area away from incompatible substances such as oxidizers. Minimize exposure to moisture and direct sunlight. Proper labeling and adherence to local regulations for storage and handling of hazardous chemicals are essential. |
| Shelf Life | Shelf life: Store 6-Chloroimidazo[1,2-a]pyridine-3-carbaldehyde in a cool, dry place; stable for at least two years. |
|
Purity 98%: 6-Chloroimidazo[1,2-a]pyridine-3-carbaldehyde with purity 98% is used in pharmaceutical intermediate synthesis, where it ensures high yield and minimal side-product formation. Melting Point 110-113°C: 6-Chloroimidazo[1,2-a]pyridine-3-carbaldehyde with melting point 110-113°C is used in organic synthesis protocols, where it supports controlled thermal processing and reproducible crystallization. Stability Temperature up to 60°C: 6-Chloroimidazo[1,2-a]pyridine-3-carbaldehyde with stability temperature up to 60°C is used in storage and transportation of lab reagents, where it maintains chemical integrity and reduces degradation risk. Molecular Weight 192.59 g/mol: 6-Chloroimidazo[1,2-a]pyridine-3-carbaldehyde with molecular weight 192.59 g/mol is used in drug discovery workflows, where accurate molar calculations advance reliable formulation. Particle Size <10 μm: 6-Chloroimidazo[1,2-a]pyridine-3-carbaldehyde with particle size <10 μm is used in solid-phase synthesis, where it enhances surface contact and reaction efficiency. Solubility in DMSO: 6-Chloroimidazo[1,2-a]pyridine-3-carbaldehyde with solubility in DMSO is used in high-throughput screening assays, where it enables homogeneous sample preparations and reproducible assay results. HPLC Assay ≥ 98%: 6-Chloroimidazo[1,2-a]pyridine-3-carbaldehyde with HPLC assay ≥ 98% is used in analytical reference standards, where it ensures consistent quantification and method validation. Low Water Content (<0.5%): 6-Chloroimidazo[1,2-a]pyridine-3-carbaldehyde with low water content (<0.5%) is used in moisture-sensitive reactions, where it prevents unwanted hydrolysis and maintains reaction fidelity. |
Competitive 6-Chloroimidazo[1,2-a]pyridine-3-carbaldehyde prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@boxa-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@boxa-chem.com
Flexible payment, competitive price, premium service - Inquire now!
As a chemical manufacturer, we draw from years of practical experience working with heterocyclic building blocks. Among these, 6-Chloroimidazo[1,2-a]pyridine-3-carbaldehyde stands out—not for hype, but because it meets the growing needs of both research and industry. This compound’s core structure, an imidazopyridine ring chlorinated at the 6-position and featuring an aldehyde group at position 3, offers unique synthetic leverage. Chemists seeking reliability and versatility in their reactions have increasingly turned to this molecule, especially when developing new pharmaceuticals or advanced materials.
Producing 6-Chloroimidazo[1,2-a]pyridine-3-carbaldehyde involves more than standard synthesis. Early batches taught us that purity swings of even a couple percent could stall downstream reactions or muddy analytical results. Careful control of both temperature and solvent choice during the cyclization and chlorination stages became central to consistent production. Our typical batches feature purity above 98 percent by HPLC, supported by well-documented NMR and MS spectra. Yield can fluctuate alongside seasonal temperature shifts, especially in regions relying on non-climate-controlled facilities, so we’ve built in recalibration steps at multiple points in the process—something learned through users’ feedback, rather than internal speculation.
Some might quote standard specs: melting point, color, assay. Direct feedback from formulation chemists told us that trace byproducts—not always flagged in routine purity tests—can complicate scale-up or bioassay consistency. We regularly screen for related impurities down to 0.1 percent, with particular attention to residual starting materials like 2-chloropyridine and oxidation byproducts. Water content, usually around 0.1 percent by Karl Fischer titration, can swing higher if storage conditions slip—leading us to tighten our packaging protocols. In one instance, a researcher’s inconsistent reaction yields traced back to aldehyde hydration from improperly handled material, leading us to modify container sealing and pre-shipment checks.
The imidazo[1,2-a]pyridine core appears in an expanding list of lead drug candidates and agrochemical agents. Incorporating a chlorine atom on the ring, coupled with the accessible aldehyde, opens the molecule to robust derivatization. Condensation reactions, especially with amines, proceed smoothly under mild conditions—an advantage when temperature-sensitive groups are present. We’ve seen rapid uptake by teams optimizing kinase inhibitors, thanks to the ring’s electron profile and the positioning of the chlorine. Unlike unsubstituted imidazopyridines, this derivative resists over-oxidation and can be selectively functionalized further, a fact confirmed by several customers sending us analytical results of their extended syntheses.
The comparison with 6-bromo- or 6-methyl-imidazo[1,2-a]pyridine-3-carbaldehyde underlines some practical differences. Chlorine’s electron-withdrawing nature in this scaffold shifts the reactivity profile, slowing oxidative degradation while demanding more careful catalyst choice in cross-coupling. We routinely field questions on differences in coupling yield between chloro- and bromo- derivatives, and have found that palladium-based systems, for instance, require higher loading with the chloro analog. These outcomes aren’t always evident in published literature; direct bench experience sorting through catalyst screens confirmed what specs alone couldn't predict. Our technical support team won’t default to bromo or iodo analogs just for the “easier coupling” headline; they’ll discuss tradeoffs in byproduct formation or cost.
Our own observations, confirmed by partners, suggest several leading-edge uses. Medicinal chemists value this aldehyde’s compatibility with a wide array of functional groups, letting them explore diverse libraries of potential bioactives. The aldehyde group readily forms Schiff bases and other imines, supporting SAR studies without cumbersome protection-deprotection cycles. Material scientists have reported success in leveraging the compound’s rigid backbone to construct novel emissive molecules or ligands. We followed a collaborative project where modifications at the 3-position, enabled by our clean aldehyde, gave rise to heterocyclic fluorophores outperforming earlier generations in both brightness and photostability.
Manufacturers often focus on what leaves the plant, but customer feedback starts when the drums or bottles open. Tackling sensitivity to moisture head-on, we pack 6-Chloroimidazo[1,2-a]pyridine-3-carbaldehyde in nitrogen-flushed glass containers. Even so, we stress to partners that prolonged exposure to ambient air, especially during high-humidity months, can lead to hydrolysis of the aldehyde. Not every lab maintains a glovebox, so desiccant pouches and clear storage and transfer protocols make a real difference. In one instance, a series of failed reactions in a partner’s lab traced to repeated exposure during bench-scale subsampling; this prompted us to provide detailed storage-to-bench workflow recommendations, which cut error rates dramatically for subsequent batches.
Internal audits rely on trend lines and certificates, but real-world problems drive actual improvement. A pharmaceutical pilot site flagged micro-level contamination from a glass vial closure, which only turned up after their scale-up. From that case, we overhauled our capping material and accelerated integration of small-scale feedback into lot release criteria. Lot-to-lot consistency doesn’t depend solely on hitting analytical benchmarks, but also on openly sharing batch data and rapidly integrating partner labs’ anomaly reports. We welcome external audits, going beyond minimum barcodes or tamper-seals to provide direct chemical and application support from the same chemists running production.
Market supply for building blocks like 6-Chloroimidazo[1,2-a]pyridine-3-carbaldehyde constantly fluctuates. Natural disasters, energy price spikes, and regulatory shifts all touch both raw material cost and output timing. We plan inventory to accommodate seasonality and resin supply volatility, and don’t overpromise lead times. Once, a major pyridine precursor supplier ran into regulatory delays, which pushed many intermediate outages down the supply chain. Thanks to routine scenario planning and multi-source contracts, we honored delivery to both regular and first-time clients—though not always at originally posted prices. Communicating hard realities upfront, not as afterthoughts, keeps trust intact throughout the supply chain.
Direct production sharpens decision-making. We don’t depend on distant third parties for our core reactions or final QC. This direct engagement lets us provide insights impossible to glean from reseller brochures or catalog sheets. Technicians and chemists exchange lessons weekly: a failed crystallization batch, a single HPLC spike, or reactions to a newly sourced solvent all find their way into our internal process documents and, when needed, into direct lines with our partners. That’s how incremental improvements turn into robust, reliable manufacturing strategies.
Questions about compatibility with certain solvents or resins, or about subtle product differences, arrive daily. Experience counts most when a researcher describes a borderline solubility issue or unexplained reactivity difference versus a similar building block. Our technical team, often the same people running the reactors, answers these with more than book knowledge. A synthesis chemist needing advice on metal-catalyzed cross-coupling in non-polar solvents draws from notes kept during actual runs where trace water or batch age affected conversion. The ability to pull on that experience gives users a head start over pure literature research.
No two applications treat 6-Chloroimidazo[1,2-a]pyridine-3-carbaldehyde exactly the same. Some want the aldehyde in bulk for high-throughput screening, others require ultra-fine purity or a specific particle size for pilot-scale reactions. Our process shifts accordingly. Early on, bulk users flagged filtration steps as a bottleneck, prompting us to retool our crystallization-separation procedure for more uniform output. Small-batch medicinal chemists, on the other hand, requested packaging in amber vials for extended shelf life, something we implemented after tracking degradation rates over several months. This willingness to adjust parallels the diversity seen in product use, from multi-kilo process runs to milligram-scale library synthesis.
Unlike some restricted intermediates, 6-Chloroimidazo[1,2-a]pyridine-3-carbaldehyde avoids the most stringent reporting requirements, but certain export destinations require paperwork attesting to purity and intended use. Documentation, often overlooked until the last minute, influences whether a timely shipment becomes a customs bottleneck. We maintain up-to-date inventory and batch records as well as exporter declarations, streamlining this process in response to real-world requests, not theoretical best practices. Our regulatory team monitors shifting international codes, advising both longstanding and newer partners on anticipated bottlenecks and compliance needs. That approach minimizes risk at the delivery dock and in regulatory review alike.
Hiccups occur, and how a manufacturer reacts shapes long-term reliability. Few forget the time a filtration media contaminant ended up in two consecutive batches, only flagged after a customer’s instrumental analysis caught a persistent trace signal. Management pulled together both production and quality teams within hours, traced the source to a specific supplier, swapped in new media, and resent samples. Years of industry talk about responsiveness mean little without that sort of open collaboration, and direct experience shows that customers value transparency in both failure and resolution.
Production of heterocyclic aldehydes like this one poses real environmental stewardship challenges. Waste minimization isn’t just a slogan; solvent recycling and byproduct stream optimization shave both costs and emissions. Our facility tracks solvent use and energy demand per batch, benchmarks against prior quarters, and regularly upgrades containment and scrubbing systems. Workers receive regular hazard training—not just paperwork, but spot drills and process reviews. Local regulators inspect our plant routinely, and our safety record draws from proactive hazard prediction and reporting, not just box-ticking on inspection sheets. User safety extends downstream, too, so we share updated handling advice and familiarity with aldehyde reactivity hazards with every order out the door.
6-Chloroimidazo[1,2-a]pyridine-3-carbaldehyde stands testament to the value of continuous improvement based on direct feedback and in-house experience. The compound will likely see even broader use as medicinal and materials chemistry advance in complexity and scale. User input regarding new coupling conditions, storage requirements, or even minor stability quirks guides our process refinement path. As we’ve seen, robust performance on the bench and in the plant depends not only on molecular structure, but on the sum of procedural improvements, attentive technical support, and shared problem-solving across the production chain. The evolution of this product, like many specialized intermediates, draws from daily lessons, technical discussion, and transparent problem resolution. We see each kilogram shipped as the outcome of that ongoing process.